New targeted therapy for cancer in veterans
Targeted nanoTherapy to Precision Oncology Platform (TnT POP) for Veterans
This study is exploring a new way to help veterans who are at higher risk for cancer because of toxin exposure, by using tiny particles that can target cancer cells and change their cholesterol levels to make treatments work better for tough-to-treat cancers.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Jesse Brown VA Medical Center NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-10922028 on NIH RePORTER |
What this research studies
This research focuses on developing a novel treatment approach for veterans who are at increased risk of cancer due to exposure to toxins. The team has discovered that certain cancers, particularly those resistant to traditional therapies like chemotherapy and radiation, share a common metabolic profile. By using specially engineered nanoparticles that target cancer cells, the research aims to improve treatment outcomes by effectively modulating cholesterol levels in these cells. This innovative approach could lead to more effective therapies for difficult-to-treat cancers.
Who could benefit from this research
Good fit: Ideal candidates for this research are veterans diagnosed with cancers that are resistant to standard treatments.
Not a fit: Patients who do not have cancer or those with cancers that respond well to existing therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a new, effective treatment option for veterans suffering from resistant cancers.
How similar studies have performed: While the approach of using engineered nanoparticles for cancer treatment is innovative, similar strategies have shown promise in other research, indicating potential for success.
Where this research is happening
Chicago, United States
- Jesse Brown VA Medical Center — Chicago, United States (Active)
Researchers
- Principal investigator: Thaxton, Colby Shad — Jesse Brown VA Medical Center
- Study coordinator: Thaxton, Colby Shad
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.